Evidence map›Paper›PMID 27605172›Full record

ArticleNeurology2016

Hormone replacement in menopausal women with multiple sclerosis: Looking back, thinking forward.

Rhonda Voskuhl, Francesco Patti

Registry-linked trialAbstract readEditorialComment
PubMed Publisher
In one paragraph

Article in Neurology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01466114 (A Double-Blind, Placebo Controlled Trial of Estriol Treatment in Women With Multiple Sclerosis), which is not on this map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01466114 phase2unknown statusnot on this map

A Double-Blind, Placebo Controlled Trial of Estriol Treatment in Women With Multiple Sclerosis: Effect on Cognition.

TypeinterventionalSponsorUniversity of California, Los AngelesRan2011 to 2022Enrolled64ConditionsRelapsing-remitting Multiple Sclerosis, Secondary-progressive Multiple Sclerosis, Primary-progressive Multiple SclerosisArmsestriol, Placebo, Norethindrone, Progestin Placebo
3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Observational
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Rhonda VoskuhlFrom the Multiple Sclerosis Program (R.V.), Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles; and Department of Medical, Surgical Sciences, and Advanced Technologies (F.P.), G.F. Ingrassia, University of Catania, Italy. rvoskuhl@ucla.edu.
Francesco PattiFrom the Multiple Sclerosis Program (R.V.), Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles; and Department of Medical, Surgical Sciences, and Advanced Technologies (F.P.), G.F. Ingrassia, University of Catania, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Multiple SclerosisFemaleHormone Replacement TherapyHumansMenopausePostmenopauseQuality of Life

Identifiers

PMID27605172

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.